Consonance Capital Management LP - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 64 filers reported holding OVID THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Consonance Capital Management LP ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$18,947,000
+146.4%
2,570,878
-0.4%
1.14%
+98.1%
Q1 2020$7,691,000
-35.8%
2,580,878
-10.7%
0.57%
-21.7%
Q4 2019$11,989,0002,888,8880.73%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders